Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.570
-0.020 (-1.26%)
At close: Nov 20, 2024, 4:00 PM
1.650
+0.080 (5.10%)
After-hours: Nov 20, 2024, 6:50 PM EST
Fortress Biotech Market Cap
Fortress Biotech has a market cap or net worth of $43.27 million as of November 20, 2024. Its market cap has increased by 105.09% in one year.
Market Cap
43.27M
Enterprise Value
22.61M
1-Year Change
105.09%
Ranking
Category
Stock Price
$1.57
Market Cap Chart
Since November 17, 2011, Fortress Biotech's market cap has decreased from $77.30M to $43.27M, a decrease of -44.02%. That is a compound annual growth rate of -4.36%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 43.90M | 63.20% |
Dec 29, 2023 | 26.90M | -62.17% |
Dec 30, 2022 | 71.10M | -71.46% |
Dec 31, 2021 | 249.10M | -16.13% |
Dec 31, 2020 | 297.00M | 63.28% |
Dec 31, 2019 | 181.90M | 273.51% |
Dec 31, 2018 | 48.70M | -75.90% |
Dec 29, 2017 | 202.10M | 53.11% |
Dec 30, 2016 | 132.00M | 0.38% |
Dec 31, 2015 | 131.50M | 21.65% |
Dec 31, 2014 | 108.10M | 15.37% |
Dec 31, 2013 | 93.70M | -14.74% |
Dec 31, 2012 | 109.90M | 140.48% |
Dec 30, 2011 | 45.70M | -40.88% |
View and export this data all the way back to 2011.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Actinium Pharmaceuticals | 44.92M |
Xilio Therapeutics | 44.83M |
SCYNEXIS | 44.77M |
Serina Therapeutics | 44.46M |
Gain Therapeutics | 43.92M |
Daxor | 43.51M |
Achilles Therapeutics | 43.14M |
OncoCyte | 42.93M |